105
Views
23
CrossRef citations to date
0
Altmetric
Original Research

Prognostic values of baseline, interim and end-of therapy 18F-FDG PET/CT in patients with follicular lymphoma

, , , , , & show all
Pages 6871-6885 | Published online: 23 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ross Thomas Salvaris & Chan Yoon Cheah. (2022) Time to omit interim CT imaging during frontline chemoimmunotherapy for patients with follicular lymphoma?. Leukemia & Lymphoma 63:14, pages 3271-3273.
Read now
Farheen Manji, Sita Bhella, Robert Kridel, Vishal Kukreti, John Kuruvilla, Anca Prica & Michael Crump. (2022) Clinical utility of interim CT scans in patients receiving chemoimmuntherapy for first line treatment of follicular lymphoma. Leukemia & Lymphoma 63:14, pages 3402-3408.
Read now

Articles from other publishers (21)

Ahmed El-Azony, Mohammad Abd Alkhalik Basha, Yassir Edrees Almalki, Bader Abdelmaksoud, Nabila Hefzi, Ahmed A. Alnagar, Sheren Mahdey, Ismail Mohamed Ali, Ibrahim Nasr, Ahmed A. El-Hamid M. Abdalla, Hala Y. Yousef, Mohamed M. A. Zaitoun, Saeed Bakry Elsayed, Mohamad Gamal Nada, Mohamed I. Amin, Rania Mostafa Hassan, Susan Adil Ali, Tamer Mahmoud Dawoud, Sameh Abdelaziz Aly, Youssef H. Algazzar & Heba Abdelhamed. (2023) The prognostic value of bone marrow retention index and bone marrow-to-liver ratio of baseline 18F-FDG PET/CT in diffuse large B-cell lymphoma. European Radiology 34:4, pages 2500-2511.
Crossref
Kim M. Linton, Lena Specht, Astrid Pavlovsky, Carrie A. Thompson, Eva Kimby, Daphne de Jong, Loretta J. Nastoupil, Anne‐Ségolène Cottereau, Carla Casulo, Clémentine Sarkozy & Jessica Okosun. (2023) Personalised therapy in follicular lymphoma – is the dial turning?. Hematological Oncology.
Crossref
Lucia Leccisotti, Daria Maccora, Rosalia Malafronte, Francesco D’Alò, Elena Maiolo, Salvatore Annunziata, Vittoria Rufini, Alessandro Giordano & Stefan Hohaus. (2022) Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden. Journal of Cancer Research and Clinical Oncology 149:7, pages 2783-2791.
Crossref
Lucia Zanoni, Davide Bezzi, Cristina Nanni, Andrea Paccagnella, Arianna Farina, Alessandro Broccoli, Beatrice Casadei, Pier Luigi Zinzani & Stefano Fanti. (2023) PET/CT in Non-Hodgkin Lymphoma: An Update. Seminars in Nuclear Medicine 53:3, pages 320-351.
Crossref
Merissa N. Zeman, Esma A. Akin, Reid W. Merryman & Heather A. Jacene. (2023) Interim FDG-PET/CT for Response Assessment of Lymphoma. Seminars in Nuclear Medicine 53:3, pages 371-388.
Crossref
Na Sun, Wenli Qiao, Yan Xing, Taisong Wang & Jinhua Zhao. (2023) Prognostic value of interim 18F-FDG PET/CT in adult follicular lymphoma treated with R-CHOP. Annals of Hematology 102:4, pages 795-800.
Crossref
Reid W. Merryman, Laure Michaud, Robert Redd, Patrizia Mondello, Hyesun Park, Gabriela Spilberg, Matthew Robertson, Eleanor Taranto, Gulrayz Ahmed, Matthew Chase, Erin Jeter, Inhye E. Ahn, Jennifer R. Brown, Jennifer Crombie, Matthew S. Davids, David C. Fisher, Eric Jacobsen, Caron A. Jacobson, Austin I. Kim, Ann S. LaCasce, Samuel Y. Ng, Oreofe O. Odejide, Erin M. Parry, Gilles Salles, Andrew D. Zelenetz, Philippe Armand, Heiko Schöder & Heather Jacene. (2023) Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma. HemaSphere 7:2, pages e826.
Crossref
Zahra Kiamanesh, Narjess Ayati, Ramin Sadeghi, Eliza Hawkes, Sze Ting Lee & Andrew M. Scott. (2022) The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review. European Journal of Nuclear Medicine and Molecular Imaging 49:13, pages 4661-4676.
Crossref
Ádám Jóna, Anna Kenyeres, Sándor Barna, Árpád Illés & Zsófia Simon. (2022) Clinical and biological prognostic factors in follicular lymphoma patients. PLOS ONE 17:8, pages e0272787.
Crossref
Hongyan Li, Min Wang, Yajing Zhang, Fan Hu, Kun Wang, Chenyang Wang & Zairong Gao. (2022) Prediction of prognosis and pathologic grade in follicular lymphoma using 18F-FDG PET/CT. Frontiers in Oncology 12.
Crossref
A. Díaz-Silván, L.F. Otón-Sánchez, A.P. Caresia-Aróztegui, M. del Puig Cózar-Santiago, J. Orcajo-Rincón, M. de Arcocha-Torres, R.C. Delgado-Bolton & D. Cabello-García. (2022) Clinical application of [18F]FDG PET/CT in follicular lymphoma. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 41:3, pages 202-212.
Crossref
A. Díaz-Silván, L.F. Otón-Sánchez, A.P. Caresia-Aróztegui, M. del Puig Cózar-Santiago, J. Orcajo-Rincón, M. de Arcocha-Torres, R.C. Delgado-Bolton & D. Cabello-García. (2022) Aplicación clínica de la [18F]FDG PET/TC en el linfoma folicular. Revista Española de Medicina Nuclear e Imagen Molecular 41:3, pages 202-212.
Crossref
Mayara L. C. Dourado, Luca T. Dompieri, Glauber M. Leitão, Felipe A. Mourato, Renata G. G. Santos, Paulo J AlmeidaFilhoFilho, Brivaldo MarkmanFilhoFilho, Marcelo D. T. Melo & Simone C. S. Brandão. (2022) Aumento de Captação Cardíaca de 18F-FDG Induzida por Quimioterapia em Pacientes com Linfoma: Um Marcador Precoce de Cardiotoxicidade?. Arquivos Brasileiros de Cardiologia.
Crossref
Atsushi Kagimoto, Yasuhiro Tsutani, Takahiro Mimae, Yoshihiro Miyata & Morihito Okada. (2022) Segmentectomy versus lobectomy for solid predominant cN0 lung cancer: analysis using visual evaluation of positron emission tomography. European Journal of Cardio-Thoracic Surgery 61:2, pages 279-286.
Crossref
Manar Mohamed Naguib, Samer Malak Botros, Amir Louis Louka & Rasha S. Hussein. (2021) Role of PET/CT in initial evaluation of lymphoma patients. Egyptian Journal of Radiology and Nuclear Medicine 52:1.
Crossref
Giovanni Manfredi Assanto, Giulia Ciotti, Mattia Brescini, Maria Lucia De Luca, Giorgia Annechini, Gianna Maria D’Elia, Roberta Agrippino, Ilaria Del Giudice, Maurizio Martelli, Agostino Chiaravalloti & Alessandro Pulsoni. (2021) High Basal Maximal Standardized Uptake Value (SUVmax) in Follicular Lymphoma Identifies Patients with a Low Risk of Long-Term Relapse. Cancers 13:12, pages 2876.
Crossref
Imke E. Karsten, Gabriele Reinartz, Michaela Pixberg, Kai Kröger, Michael Oertel, Birte Friedrichs, Georg Lenz & Hans Theodor Eich. (2021) Radiotherapy in Follicular Lymphoma Staged by 18F-FDG-PET/CT: A German Monocenter Study. Biomedicines 9:5, pages 561.
Crossref
Atsushi Kagimoto, Yasuhiro Tsutani, Yoshinori Handa, Takahiro Mimae, Yoshihiro Miyata & Morihito Okada. (2020) Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma. Annals of Surgical Oncology 28:4, pages 2068-2075.
Crossref
Juan Carlos Prieto Prieto, Juan Antonio Vallejo Casas, Eleftheria Hatzimichael, Andreas Fotopoulos, Dimitrios-Nikiforos Kiortsis & Chrissa Sioka. (2020) The contribution of metabolic parameters of FDG PET/CT prior and during therapy of adult patients with lymphomas. Annals of Nuclear Medicine 34:10, pages 707-717.
Crossref
Atsushi Kagimoto, Yasuhiro Tsutani, Yu Izaki, Yoshinori Handa, Takahiro Mimae, Yoshihiro Miyata & Morihito Okada. (2020) Prediction of Lymph Node Metastasis Using Semiquantitative Evaluation of PET for Lung Adenocarcinoma. The Annals of Thoracic Surgery 110:3, pages 1036-1042.
Crossref
Yeye Zhou, Xiaoyi Zhang, Haifeng Qin, Zixuan Zhao, Jihui Li, Bin Zhang, Shibiao Sang, Yiwei Wu & Shengming Deng. (2020) Prognostic Values of Baseline 18 F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma . BioMed Research International 2020, pages 1-10.
Crossref